Skip to content
Profiles

PepGen Inc

PepGen Inc is a clinical stage biotechnology company whereby using their proprietary Enhanced Delivery Oligonucleotide (EDO) platform, they are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological diseases.

CMT1A